Journal ArticleOPEN ACCESS

Seroconversion Rates after the Second COVID-19 Vaccination in Patients with Systemic Light Chain (AL) amyloidosis

HemaSphere (2022) 6(3) E688
DOI: 10.1097/HS9.0000000000000688
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Liebers, N., Schönland, S. O., Speer, C., Edelmann, D., Schnitzler, P., Kräusslich, H. G., … Dietrich, S. (2022). Seroconversion Rates after the Second COVID-19 Vaccination in Patients with Systemic Light Chain (AL) amyloidosis. HemaSphere, 6(3), E688. https://doi.org/10.1097/HS9.0000000000000688

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free